# Call For Review: Phoenix V3 RTDBSCAN Continuation-Bottleneck No-Go

Reviewer: Claude or Gemini.

Project: RTDL Phoenix V3 rebuild.

## Review Target

Please critically review this V3-only decision:

```text
docs/rebuild/v3/phoenix_v3_rtdbscan_continuation_bottleneck_no_go_2026-06-21.md
docs/rebuild/v3/phoenix_v3_rtdbscan_continuation_bottleneck_no_go_2026-06-21.json
tutorials/current/09_rtdbscan_component_signature_route_split.md
```

Evidence sources referenced by the packet:

```text
docs/rebuild/v3/evidence/phoenix_v3_rtdbscan_same_contract_20260620_fresh/summary.json
docs/rebuild/v3/phoenix_v3_rtdbscan_same_contract_pod_evidence_2026-06-20.md
docs/rebuild/v3/evidence/phoenix_v3_m4_grouped_continuation_20260620/m23_dbscan_component_signature_524288.json
```

## Intended Decision

RTDBSCAN should not be promoted to M7 from current evidence.

Reason:

- same-contract overall OptiX-over-Embree speedups are only 1.150x, 1.079x,
  and 1.071x for serious rows;
- at 262,144 and 524,288 points, the shared Numba component-signature
  continuation dominates OptiX wall time;
- M23 grouped-stream component-signature evidence is useful internal evidence,
  but it is a different contract with no same-scale Embree baseline;
- old `1483.603x` all-app wording is not usable public evidence.

## Questions For The Reviewer

1. Is the no-go decision technically justified by the cited evidence?
2. Are the route boundaries clear enough to prevent public overclaiming?
3. Are the reopen requirements sufficient?
4. Is any wording still misleading for users?
5. Would you approve this as an internal V3 blocker packet, not as a release
   performance claim?

## Required Review Style

Please be strict. Prefer rejection over ambiguous approval. Call out any route
mixing, hidden claim escalation, missing validation, or missing evidence.
